Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Comment by quinlashon Oct 17, 2024 11:51pm
76 Views
Post# 36271030

RE:RE:Canopy Growth reduces term loan by US$100 million

RE:RE:Canopy Growth reduces term loan by US$100 million
BrokerG wrote: Bassd on my analyis/research, the reduction in the term loan of $100 million, eliminates the odds of bankrupcty in Canopy until December 2026. If the US can't get anything passed until then, then we are all screw**d. Overall positive, but in actuality, the repayment was part of the Loan covenant. However, I love how Canopy spun it to look like they are going above and beyond the debt repayment terms.

Still holding until Spring 2025.


Maybe you did this already but just in case, take into account your own projected incremental net sales from Canopy Medical. 

I haven't dug into that for awhile but I doubt it would take too long to figure out 

TC

Q
<< Previous
Bullboard Posts
Next >>